Report for Porter R

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (4)

Title : A randomized, placebo-controlled study investigating the nicotinic alpha7 agonist, RG3487, for cognitive deficits in schizophrenia - Umbricht_2014_Neuropsychopharmacology_39_1568
Author(s) : Umbricht D , Keefe RS , Murray S , Lowe DA , Porter R , Garibaldi G , Santarelli L
Ref : Neuropsychopharmacology , 39 :1568 , 2014
Abstract : Umbricht_2014_Neuropsychopharmacology_39_1568
ESTHER : Umbricht_2014_Neuropsychopharmacology_39_1568
PubMedSearch : Umbricht_2014_Neuropsychopharmacology_39_1568
PubMedID: 24549101

Title : RG3487, a novel nicotinic alpha7 receptor partial agonist, improves cognition and sensorimotor gating in rodents - Wallace_2011_J.Pharmacol.Exp.Ther_336_242
Author(s) : Wallace TL , Callahan PM , Tehim A , Bertrand D , Tombaugh G , Wang S , Xie W , Rowe WB , Ong V , Graham E , Terry AV, Jr. , Rodefer JS , Herbert B , Murray M , Porter R , Santarelli L , Lowe DA
Ref : Journal of Pharmacology & Experimental Therapeutics , 336 :242 , 2011
Abstract : Wallace_2011_J.Pharmacol.Exp.Ther_336_242
ESTHER : Wallace_2011_J.Pharmacol.Exp.Ther_336_242
PubMedSearch : Wallace_2011_J.Pharmacol.Exp.Ther_336_242
PubMedID: 20959364

Title : Poster: Effects of RG3487 at the alpha7\/beta2 nicotinic acetylcholine receptor expressed in Xenopus oocytes -
Author(s) : Wallace TL , Porter R , Neveu E , Bertrand D
Ref : Biochemical Pharmacology , 82 :1026 , 2011
PubMedID:

Title : Poster: R3487\/MEM 3454, a novel nicotinic alpha 7 receptor partial agonist, improves attention and working memory performance in cynomolgus macaques -
Author(s) : Wallace TL , Chiu G , Dao H , Lowe DA , Porter R , Santarelli L
Ref : Biochemical Pharmacology , 78 :912 , 2009
PubMedID: